Pharmacophore Modeling
Andrographolide Analogues: Pharmacophore Modeling and 3D QSAR analysis
7
Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures
13
Pharmacophore Modeling and 3D-QSAR Study of Acridine Derivatives for the Development of Better Antileishmanial Agents
8
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
13
Structure Based Pharmacophore Modeling to Discover Novel CCR5 Inhibitors for HIV 1/Cancers Therapy
21
VIRTUAL SCREENING, PHARMACOPHORE MODELING, AND QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP STUDIES ON HISTAMINE 4 RECEPTOR
5
PHARMACOPHORE MODELING STUDIES ON 2-ARYLIDENE-4- (SUBSTITUTED ARYL) BUT-3-EN-4-OLIDES
18
LIGAND BASE PHARMACOPHORE MODELING VRTUAL SCREENING AND DOCKING AGAINST TGFRB1 GENE MUTATION IN BREAST CANCER
16
Pharmacophore modeling studies on aryl thioxothiazolidinones as ADAMTS 5 (Aggrecanase 2) inhibitors
12
In silico identification of novel Topoisomerase I inhibitors: Application of ligand based pharmacophore modeling and chemical database mining
26
Molecular docking, pharmacophore modeling and 3D QSAR approach on a series of piperidone derivatives as potential anticancer agents by targeting the enzyme VEGFR 2 tyrosine kinase
9
Treatment against Mutation of PIK3CA Gene Involved in Lung Cancer by Structure Base Pharmacophore Modeling, Virtual Screening and Molecular Docking
14
ENERGY BASED PHARMACOPHORE MODELING, VIRTUAL SCREENING, AND MOLECULAR DYNAMICS TO IDENTIFY POTENTIAL INHIBITORS FOR GLYCOGEN SYNTHASE KINASE 3 BETA
8
3D QSAR AND PHARMACOPHORE MODELING ON SUBSTITUTED CYANOPYRROLIDINES AS TYPE II ANTI-DIABETIC AGENTS POTENTIAL DIPEPTIDYL PEPTIDASE-IV INHIBITORS
7
Pharmacophore modeling and 3D QSAR studies on flavonoids as α glucosidase inhibitors
12
Ligand based Pharmacophore Modeling of some Angiotensin II Receptor Antagonist
6
Pharmacophore modeling and 3D QSAR studies on Chalcones as Trypanosoma cruzi inhibitors
13
Pharmacophore modeling and molecular docking of phytoconstituents in Morus sp. and Arcangelisia flava against nitric oxide synthase for antiinflammatory discovery
7
QSAR AND PHARMACOPHORE MODELING BASED DRUG DESIGNING FOR SPLEEN TYROSINE KINASE (SYK) PROTEIN FOR HUMAN USING ACCELRYS DISCOVERY STUDIO SOFTWARE IN LINUX SERVER
9
Antiinflammatory Activity of Triazine Thiazolidinone Derivatives: Molecular Docking and Pharmacophore Modeling
8